about
Metabolic consequences of mitochondrial coenzyme A deficiency in patients with PANK2 mutationsAAV-mediated liver-specific MPV17 expression restores mtDNA levels and prevents diet-induced liver failureMechanical properties of growing melanocytic nevi and the progression to melanomaExpression and modulation of IFN-gamma-inducible chemokines (IP-10, Mig, and I-TAC) in human brain endothelium and astrocytes: possible relevance for the immune invasion of the central nervous system and the pathogenesis of multiple sclerosisEfficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics17q25 Locus is associated with white matter hyperintensity volume in ischemic stroke, but not with lacunar stroke status.Are myocardial infarction--associated single-nucleotide polymorphisms associated with ischemic stroke?In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells.CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells.Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals.Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapyNeutralization of schwann cell-secreted VEGF is protective to in vitro and in vivo experimental diabetic neuropathy.Hyperhomocysteinemia and other thrombophilic risk factors in 26 patients with cerebral venous thrombosis.Human fetal aorta contains vascular progenitor cells capable of inducing vasculogenesis, angiogenesis, and myogenesis in vitro and in a murine model of peripheral ischemiaAu nanoparticle-based sensor for apomorphine detection in plasma.Drug-releasing mesenchymal cells strongly suppress B16 lung metastasis in a syngeneic murine model.Overshoot during phenotypic switching of cancer cell populationsThe natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates.Human and mouse brain-derived endothelial cells require high levels of growth factors medium for their isolation, in vitro maintenance and survivalAngiogenic and anti-inflammatory properties of micro-fragmented fat tissue and its derived mesenchymal stromal cells.Probing spermiogenesis: a digital strategy for mouse acrosome classification.Establishment, characterization and long-term culture of human endocrine pancreas-derived microvascular endothelial cells.Cell-mediated drug delivery by gingival interdental papilla mesenchymal stromal cells (GinPa-MSCs) loaded with paclitaxel.Loss of CD45 cell surface expression in canine T-zone lymphoma results from reduced gene expression.Changes in Red Blood Cell membrane lipid composition: A new perspective into the pathogenesis of PKAN.Gemcitabine-releasing mesenchymal stromal cells inhibit in vitro proliferation of human pancreatic carcinoma cells.Human CD14+ cells loaded with Paclitaxel inhibit in vitro cell proliferation of glioblastoma.Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.Adipose tissue-derived stromal cells primed in vitro with paclitaxel acquire anti-tumor activity.Circulating T regulatory cells migration and phenotype in glioblastoma patients: an in vitro study.Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice.Human skin-derived fibroblasts acquire in vitro anti-tumor potential after priming with Paclitaxel.Transforming growth factor-beta1 induces microvascular abnormalities through a down-modulation of neural cell adhesion molecule in human hepatocellular carcinoma.Role of tyrosyl-DNA phosphodiesterase 1 and inter-players in regulation of tumor cell sensitivity to topoisomerase I inhibition.Increased migration of a human glioma cell line after in vitro CyberKnife irradiation.In vitro effects of Cyberknife-driven intermittent irradiation on glioblastoma cell lines.A mesenchymal stromal cell line resistant to paclitaxel that spontaneously differentiates into osteoblast-like cells.Expression of the new CXCL12 receptor, CXCR7, in gliomas.Valproic acid increases the in vitro effects of nitrosureas on human glioma cell lines.Intrathecal synthesis of onconeural antibodies in patients with paraneoplastic syndromes.
P50
Q24301033-0AA1755D-A51D-4AEA-AC00-3E6E6B90D053Q24622009-B88A5AD1-B6BB-4795-9D57-8759EA1B0786Q27342765-662467FF-C8A2-4D64-BF5B-D98AE9314552Q28216915-803D4A2A-CDA2-4B57-8599-AE99878AFAD5Q28477533-D0023171-B89C-45FD-852B-8BB85121781FQ30412878-F17776FE-23E1-42F4-A784-19D5F25775FDQ30420031-FABDA5C3-EBA4-4285-B650-1CC37577B25CQ33768138-BBAC0F01-7C6E-4EAC-9FDD-6663A1E17B0CQ33784789-58C57C96-79B0-42B7-ABC8-467EE5E52A99Q34101036-6E2B91ED-376A-4947-88AB-56865683FD67Q34113542-473A70D7-0482-4B05-8335-2623E6B9AD10Q34277175-8E06CFE1-02DD-4F0B-BA37-AE9370B96924Q35788910-4D7EE68E-0849-4B58-88BE-34A1A280A3EEQ35855557-886974F9-AA8B-40B0-A147-9011105B6B49Q35886417-21F477AA-4F4F-4979-9434-4B84293D698BQ35945960-224D941A-B967-4114-882B-22FCDC092D5DQ36192449-9E59F488-A3E4-47BB-A29F-B832693476D0Q36866151-5FC68ABB-CE7D-4F15-8A1F-AF2B540AE35AQ36880688-9DD3C796-C0EC-4B01-B6AC-D6F3DA4F91E7Q37189449-C64BC0B0-C762-44A9-8DFD-246E5EC67E35Q38721738-3D9934E3-4941-4DA2-A77B-A86DBEA11A95Q38731106-6B266F56-1AEA-4C2D-BA8C-18BA7FFE9D6AQ38785582-447966A0-AD1D-44AE-BFC8-D4F441FE459FQ38791530-FED8CD30-B46C-4860-BF02-BFA1B097E24FQ38812940-6315179F-FBFF-48FD-B428-5C1CBC45B01DQ38826729-7E9613FB-C8BB-494A-AD6D-5AC9B7B65A88Q38933927-96F1FBE5-E288-4132-9F18-7455D1B9F6F7Q38969541-C872BDD9-5339-4F36-BCA8-3B74E5863100Q39094393-6830E081-D4BA-4077-91E9-285FA5CD3D26Q39100186-E9771946-57ED-411A-8FFF-7245638A4619Q39215411-7C9920A5-8C2E-4075-A7E6-4E75BB5C8764Q39288934-2B4B64D6-C547-42CF-A0AA-545BABE81452Q39325325-7E69048A-8332-407A-95A9-CFCD09E15162Q39462327-B45C2552-AB17-4DBE-B76F-4482BAE63321Q39503441-ADF0E451-3F2F-4D93-9BFF-D6488EC79BF2Q39596232-B5C72C57-3897-4841-9178-58925032A331Q39614800-E7580064-5DF3-4C5D-BB56-D21410F645B4Q39630469-03919D51-1631-4AE7-BBF8-0233AC80A4F0Q40024948-1F8E465B-0D10-485C-9965-CA2FB6CD190BQ40164269-F5A8839C-7814-4553-B1B4-4F215FEF35FC
P50
description
Italian neurological biochemist
@en
wetenschapper
@nl
հետազոտող
@hy
name
Emilio Ciusani
@ast
Emilio Ciusani
@en
Emilio Ciusani
@es
Emilio Ciusani
@nl
Emilio Ciusani
@sl
type
label
Emilio Ciusani
@ast
Emilio Ciusani
@en
Emilio Ciusani
@es
Emilio Ciusani
@nl
Emilio Ciusani
@sl
prefLabel
Emilio Ciusani
@ast
Emilio Ciusani
@en
Emilio Ciusani
@es
Emilio Ciusani
@nl
Emilio Ciusani
@sl
P1053
J-9822-2016
P1153
6701762120
P2038
Emilio_Ciusani
P21
P31
P3829
P496
0000-0002-7285-123X